Blogs about: Follow On Biologics
Featured Blog
Trends Update -- Biosimilars: Sen. Kennedy, Gov. Dean and NVCA Study all Support 12+ Years of Exclusivity
The debate over the proper data exclusivity period for innovator biologics (as protection against biosimilars/follow-on biologics/subsequent-entry biologics) had a busy week last week. On Wednesday, … more →
The Cross-Border Biotech Blog
Trends Update -- Biosimilars: Sen. Kennedy, Gov. Dean and NVCA Study all Support 12+ Years of Exclusivity
Jeremy G wrote 5 days ago: The debate over the proper data exclusivity period for innovator biologics (as protection against bi … more →
Trends Update -- Biosimilars: Obama Administration Supports 7-Year Exclusivity Period
— 1 comment
Jeremy G wrote 2 weeks ago: The Obama administration offered up a 7-year data exclusivity period for biologics, calling it a … more →
For July 4: Let's Thank the Inventors
margaritaatbio wrote 2 weeks ago: For this week’s IP News Weekly, I emphasized stories about research breakthroughs and U.S. hea … more →
Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights
margaritaatbio wrote 2 weeks ago: Chris Holman, Professor at the University of Missouri-Kansas City School of Law and author of Holman … more →
FTC Weighs In: Favors Compromise on Biosimilars Exclusivity, Disfavors Pay-For-Delay
— 4 comments
Jeremy G wrote 1 month ago: The FTC released a report today that explores the economics of biosimilars’ market entry and c … more →
BIO 2009: Monday Technology Transfer Breakfast
Jeremy G wrote 2 months ago: I was at breakfast yesterday morning with university and company members of the BIO Technology Trans … more →
Canada's First Subsequent Entry Biologic!
— 1 comment
Jeremy G wrote 2 months ago: Guest post from Jill Daley, part of our all-star life sciences team at Ogilvy: Today, Sandoz Canada … more →
Wednesday Brain Dump: Two of Everything! Edition
Jeremy G wrote 3 months ago: Two Camels! Dolly the cloned sheep, meet Injaz the cloned camel. Two R&D Heads! The combined P … more →
Trends in 2009: Shifting IP Constituencies as Innovator Pharma Buys Generics and Asia Turns to Innovation
— 10 comments
Jeremy G wrote 3 months ago: Growing industrial and geopolitical realignment of economic interests has the potential to re-define … more →
Waxman Drives Hard Bargain on FOBs Market Exclusivity
— 3 comments
dorganpeters wrote 4 months ago: Representatives Waxman (D-CA), Pallone (D-NJ) and Deal (R-GA) released the Promoting Innovation and … more →
Wednesday Brain Dump: March 11, 2009
Jeremy G wrote 4 months ago: Regulatory Brain Dump… Regulating Nanotech: The FDA is collaborating with the Houston-based A … more →
BIO's Jim Greenwood Briefs Media on Biotech Issues
— 2 comments
danmcgirt wrote 4 months ago: BIO President & CEO Jim Greenwood hosted a media briefing for reporters, editors and bloggers on … more →
GTC Biotherapeutics goes for a Regulatory Double Combo Shot
Jeremy G wrote 4 months ago: GTC Biotherapeutics, which recently saw ATryn approved, announced a collaboration agreement with AgR … more →
Teva Decides Not to Wait for U.S. Biosimilars Legislation
— 1 comment
Jeremy G wrote 4 months ago: In Beni’s post earlier this week on Biosimilars, he identified two major challenges to introdu … more →
Trends in 2009: Facing the Challenges of Introducing Biosimilars or Follow-on Biologics in the North American Market
— 2 comments
brovinski wrote 5 months ago: The so-called biotechnology drugs or biologics (large, complex protein molecules derived from living … more →
BIO leaders Joshua Boger and Jim Greenwood discuss challenges and opportunities for the biotech industry in the Obama Administration and the new Congress
— 3 comments
danmcgirt wrote 8 months ago: In BIOtech Now’s exclusive interview with Dr. Joshua Boger (Chairman and CEO of Vertex Pharmac … more →
BIO's Joshua Boger and Jim Greenwood Media Briefing
danmcgirt wrote 10 months ago: BIO President & CEO Jim Greenwood and the Chair of BIO’s Board of Directors, Dr. Joshua Bo … more →
Follow-On Biologics
nicoleatbio wrote 1 year ago: Well, its official – Day 1 of the 2008 BIO International Convention has begun! We kicked off this mo … more →
Have your say. Start a blog.
See our free features →
An 
Medley
